ESLAW vs KEYS
Estrella Immunopharma Inc. (ESLAW) versus Keysight Technologies Inc (KEYS) — a side-by-side from cached financials, not a winner call.
Estrella Immunopharma Inc. (ESLAW) is a biotechnology company listed on US.
Keysight Technologies Inc (KEYS) is a scientific & technical instruments company listed on US.
ESLAW does not have a complete income-statement cache yet.
Latest reported KEYS revenue for 2026-07-31 was $5.16B. Net income was $1.03B. Revenue was up 55.7% from 2026-04-30 to 2026-07-31. KEYS currently screens at market cap $59.84B and trailing P/E 56.5.
ESLAW currently screens at market cap $0. KEYS currently screens at market cap $59.84B and trailing P/E 56.5.
Not investment advice. Open the ESLAW and KEYS stock pages for the full models.
Not investment advice.